Olga Bakharevski
About Olga Bakharevski
Olga Bakharevski is the Medical Lead for Melanoma/GU at Bristol-Myers Squibb in Melbourne, Australia, with over 15 years of experience in the pharmaceutical industry, particularly in oncology and urology.
Title
Olga Bakharevski holds the title of Medical Lead Melanoma/GU at Bristol-Myers Squibb. She spearheads the medical strategies pertaining to melanoma and genitourinary cancers.
Company
Olga Bakharevski is currently employed at Bristol-Myers Squibb in Melbourne, Australia. Her role is focused on leading the medical strategies for melanoma and genitourinary cancers, leveraging her extensive experience in oncology.
Previous Positions
Before joining Bristol-Myers Squibb in January 2018, Olga had an extensive career at various pharmaceutical companies. She served as Senior Brand Manager at CSL Behring from 2015 to 2018. At Novartis, she was Senior Brand Manager (Oncology/Urology) in 2015 for 5 months. Her tenure at GlaxoSmithKline Australia included roles such as Medical Manager Oncology/Haematology from 2014 to 2015, Senior Brand Manager (Oncology/Urology) from 2011 to 2014, Brand Manager (Hospital Products) from 2007 to 2011, and National Tenders Manager from 2005 to 2007.
Education and Expertise
Olga Bakharevski has an extensive educational background. She achieved a Doctor of Philosophy (PhD) in Medicine and a Graduate Diploma in Immunology from Monash University. Additionally, she holds a Bachelor of Medicine, Bachelor of Surgery (M.B.B.S.) from The Russian State Medical University. Her educational foundation in medicine and immunology complements her pharmaceutical industry experience, particularly in oncology and urology.
Pharmaceutical Industry Experience
Olga Bakharevski has over 15 years of experience in the pharmaceutical industry, with a primary focus on oncology and urology. Her career includes significant roles at major pharmaceutical companies where she managed brand strategy and medical leadership roles. Her experience also encompasses managing national tenders and leading medical strategies, highlighting her diverse skills in the medical and pharmaceutical sectors.